2025 CDMO pricing data for 23 clinical and commercial cell therapy development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 51 CDMOs specializing in cell therapy
MSC-based cell therapy project pricing study and an exploration of non-standardized manufacturing approaches
Technical focus on CAR-T, Stem Cells, Exosomes, MSCs, and iPSC-based therapies
Immediate access to Nice Insight's Cell Therapy Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
Access to Nice Insight's Cell Therapy CDMO Pricing Data, including price breakdowns for over 20 distinct outsourcing RFP service line items.
Access to Nice Insight's Cell Therapy CDMO Directory, including capabilities for more than 50 cell therapy outsourcing organizations across North America, Europe, and Asia.
Insights into the evolving global regulatory landscape for autologous and allogeneic cell therapies.
Competitive Benchmarking
50+ Cell Therapy CDMO Profiles
Manufacturing Challenges & Innovations
Funding Trends
Market Growth Projections
Regulatory Landscape
Over 800 hours of data collection and analysis from
interviews, primary research and progressive study.